BriaCell Therapeutics Corp. (BCTX): Capital Expenditures
$127.0K
Year ended 2026-07-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | $127.0K | n/a | 2026-10-28, From 2025-08-01 |
| No annual figure between 2024-07-31 and 2026-07-31. | |||
| 2024-07-31 | $456.8K | n/a | 2025-10-16, From 2023-08-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | 2026-07-31 | $127.0K | n/a |
| Immunic, Inc. (IMUX) | 2025-12-31 | $161.0K | -39.0% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $110.8K | n/m |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $16.0K | -89.0% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $0 | -100.0% |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | $0 | -100.0% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $346.0K | +81.2% |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | $16.0K | -92.8% |
| Elicio Therapeutics, Inc. (ELTX) | 2025-12-31 | $16.0K | -81.6% |
Compare BCTX, IMUX, KPRX, FTH side by side · Screen every company in Pharmaceutical Preparations ↗